LONDON -- The European Commission has raided pharmaceutical firms across Europe, launching a broad investigation into whether they engaged in illegal deals or abused patents to limit competition and harm consumers.
Competition commissioner Neelie Kroes says the European Union regulator suspected that drug makers had conspired to delay generic alternatives to branded medicines.
She adds that all of Europe's pharmaceutical industry is being examined to determine why generic drugs are slow to arrive on the market.
The raids and the sector inquiry, which the commission claims was not based on specific suspected violations, could lead to cartel charges against companies and …
No comments:
Post a Comment